We are analyzing https://link.springer.com/article/10.1007/s11547-014-0446-4.

Title:
Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy | La radiologia medica
Description:
Positron emission tomography, most commonly with 18F-fluorodeoxyglucose, is being used for evaluation of tumour response to therapy. Limitations of this method are associated with (1) fluorodeoxyglucose pharmacokinetic properties, (2) the detection system, (3) discrepancies between metabolic and anatomic images, and (4) acquisition standardization. Response to therapy may be evaluated with qualitative (Deauville score), semiquantitative (standardised uptake value), and quantitative methods (European Organization for Research and Treatment of Cancer; Positron Emission Tomography Response Criteria in Solid Tumours). Methods under evaluation include metabolic tumour volume, total lesion glycolysis, and heterogeneity of fluorodeoxyglucose uptake. The development of positron emission tomography scanners that have larger fields of view may facilitate tumour assessment based on kinetic modelling. Increased clinical use of these methods will depend on the development and validation of intuitive and simple analytic tools.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Insurance

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

pubmed, pet, article, tumour, google, scholar, fdg, imaging, tomography, volume, uptake, positron, med, emission, cancer, response, cas, nucl, treatment, metabolic, data, evaluation, suv, lymphoma, acquisition, petct, central, clinical, tumours, methods, effect, metabolism, partial, eur, therapy, criteria, glucose, cell, scanning, radiotracer, activity, images, glycolysis, addition, liver, patients, mol, based, analysis, oncology,

Topics {✒️}

{\mu {\text{ci}}/{\text{ml}}} nuclear medicine specialist article download pdf 18f-fdg-pet oncological studies fuzzy c-means algorithm positron emission tomography voltage-dependent anion channels $$ \delta {\text{suv}}\left de geus-oei lf joint italian-danish study magnetic resonance imaging dual-front active contours 18f-fdg pet/ct van velden fh hybrid pet-ct scanners {\mu {\text{ci}}} fdg pet-ct scan volume-based pet parameters interim-pet-scan initial ct scan segmenting fdg-pet images exclusively glucose-based metabolism positron annihilation forms privacy choices/manage cookies full size image emission tomography radiation treatment planning /{\text{id}}\left advanced-stage hodgkin lymphoma 18f-fdg pet multi-centre trials fdg radiotracer uptake ≤ liver de cabrejas ml automatic volume delineation pathological fdg uptake open access related subjects adaptive region-growing metabolic tumor burden fdg-pet scan creative commons license metastatic lymph nodes partial volume effects support cell proliferation pet-mri scan partial volume effect glucose analogue fluorodeoxyglucose de wilt jh cancer cell biology pet-ct scanning

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
         description:Positron emission tomography, most commonly with 18F-fluorodeoxyglucose, is being used for evaluation of tumour response to therapy. Limitations of this method are associated with (1) fluorodeoxyglucose pharmacokinetic properties, (2) the detection system, (3) discrepancies between metabolic and anatomic images, and (4) acquisition standardization. Response to therapy may be evaluated with qualitative (Deauville score), semiquantitative (standardised uptake value), and quantitative methods (European Organization for Research and Treatment of Cancer; Positron Emission Tomography Response Criteria in Solid Tumours). Methods under evaluation include metabolic tumour volume, total lesion glycolysis, and heterogeneity of fluorodeoxyglucose uptake. The development of positron emission tomography scanners that have larger fields of view may facilitate tumour assessment based on kinetic modelling. Increased clinical use of these methods will depend on the development and validation of intuitive and simple analytic tools.
         datePublished:2014-08-26T00:00:00Z
         dateModified:2014-08-26T00:00:00Z
         pageStart:345
         pageEnd:351
         license:https://creativecommons.org/licenses/by/4.0
         sameAs:https://doi.org/10.1007/s11547-014-0446-4
         keywords:
            Cancer
            Treatment
            Imaging
            Metabolism
            Imaging / Radiology
            Diagnostic Radiology
            Interventional Radiology
            Neuroradiology
            Ultrasound
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11547-014-0446-4/MediaObjects/11547_2014_446_Fig1_HTML.jpg
         isPartOf:
            name:La radiologia medica
            issn:
               1826-6983
               0033-8362
            volumeNumber:120
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Milan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Andrea d’Amico
               affiliation:
                     name:Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology
                     address:
                        name:Department of Diagnostic Positron Emission Tomography, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Review of clinical practice utility of positron emission tomography with 18F-fluorodeoxyglucose in assessing tumour response to therapy
      description:Positron emission tomography, most commonly with 18F-fluorodeoxyglucose, is being used for evaluation of tumour response to therapy. Limitations of this method are associated with (1) fluorodeoxyglucose pharmacokinetic properties, (2) the detection system, (3) discrepancies between metabolic and anatomic images, and (4) acquisition standardization. Response to therapy may be evaluated with qualitative (Deauville score), semiquantitative (standardised uptake value), and quantitative methods (European Organization for Research and Treatment of Cancer; Positron Emission Tomography Response Criteria in Solid Tumours). Methods under evaluation include metabolic tumour volume, total lesion glycolysis, and heterogeneity of fluorodeoxyglucose uptake. The development of positron emission tomography scanners that have larger fields of view may facilitate tumour assessment based on kinetic modelling. Increased clinical use of these methods will depend on the development and validation of intuitive and simple analytic tools.
      datePublished:2014-08-26T00:00:00Z
      dateModified:2014-08-26T00:00:00Z
      pageStart:345
      pageEnd:351
      license:https://creativecommons.org/licenses/by/4.0
      sameAs:https://doi.org/10.1007/s11547-014-0446-4
      keywords:
         Cancer
         Treatment
         Imaging
         Metabolism
         Imaging / Radiology
         Diagnostic Radiology
         Interventional Radiology
         Neuroradiology
         Ultrasound
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs11547-014-0446-4/MediaObjects/11547_2014_446_Fig1_HTML.jpg
      isPartOf:
         name:La radiologia medica
         issn:
            1826-6983
            0033-8362
         volumeNumber:120
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Milan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Andrea d’Amico
            affiliation:
                  name:Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology
                  address:
                     name:Department of Diagnostic Positron Emission Tomography, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:La radiologia medica
      issn:
         1826-6983
         0033-8362
      volumeNumber:120
Organization:
      name:Springer Milan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology
      address:
         name:Department of Diagnostic Positron Emission Tomography, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Andrea d’Amico
      affiliation:
            name:Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology
            address:
               name:Department of Diagnostic Positron Emission Tomography, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Diagnostic Positron Emission Tomography, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland

External Links {🔗}(184)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.3s.

LINK . SPRINGER . COM {}